Keyphrases
Nuclear Interactions
61%
Interaction Partner
61%
Molecular Tumor Board
55%
BCR-ABL
43%
Phosphorylation
40%
Precision Oncology
40%
Germany
39%
Molecular Diagnostics
35%
Acute Myeloid Leukemia
34%
Personalized Medicine
33%
Hematopoietic Stem Cells
33%
Oncology
33%
Myeloproliferative Neoplasms
30%
Leukemia
30%
NPM-ALK
27%
Cancer Patients
27%
Obinutuzumab
26%
Venetoclax
26%
Progression-free Survival
25%
T Cells
25%
Treatment Recommendations
24%
CD30
23%
Leukemogenesis
23%
Rare Cancer
23%
Clinical Trials
23%
Lymphoma
19%
FMS-like Tyrosine Kinase 3 (FLT3)
19%
Chronic Lymphocytic Leukemia
19%
Genome Analysis
18%
Remission
18%
Ibrutinib
17%
Autophagy
17%
Lymphomagenesis
17%
Consensus Statement
17%
Precision Cancer Medicine
17%
Molecular Therapy
17%
Bcl-xL
17%
Giant Cell
17%
CDH1
17%
Mycobacterium
17%
Induced Transformations
17%
Macrophages
17%
Nitric Oxide
17%
Oncohematology
17%
Diffuse Large B-cell Lymphoma (DLBCL)
17%
Oncogene
17%
Disease Control Rate
16%
Minimal Residual Disease
16%
Nipa
16%
Tumor
15%
Medicine and Dentistry
Neoplasm
100%
Malignant Neoplasm
66%
Diseases
57%
Cancer
53%
Acute Myeloid Leukemia
39%
Personalized Medicine
36%
Precision Oncology
34%
T Cell
33%
Oncology
31%
Hematopoietic Cell
31%
Molecular Diagnostics
26%
Medicine
26%
Venetoclax
26%
Obinutuzumab
26%
B-Cell Chronic Lymphocytic Leukemia
26%
Biological Marker
23%
Progression Free Survival
22%
Carcinogenesis
20%
Myeloproliferative Neoplasm
18%
Anaplastic Large Cell Lymphoma
17%
Ibrutinib
17%
Receptor
16%
Minimal Residual Disease
16%
Clinical Trial
15%
Exome Sequencing
14%
Myeloproliferative Disorder
14%
FMS-Like Tyrosine Kinase 3
14%
Stem Cell
13%
STAT5 Protein
13%
Programmed Death 1 Ligand 1
13%
Targeted Therapy
13%
In Vitro
12%
Oncogenic activity
12%
Molecular Profiling
12%
Leukemia
11%
Gene Expression Profiling
11%
Patient Care
11%
Positron Emission Tomography-Computed Tomography
10%
Cancer Susceptibility
10%
Immunoglobulin
10%
Cell Proliferation
10%
Overall Survival
10%
Germ Cell
9%
Upregulation
9%
Medical Oncology
9%
Drive
8%
Neuro-Oncology
8%
Tumor Cell
8%
B Cell
8%
Cenisertib
8%
Biochemistry, Genetics and Molecular Biology
Hematopoietic Cell
39%
Myeloid
35%
Genomics
35%
T Cell
31%
Kinase
31%
Phosphotransferase
31%
Carcinogenesis
29%
Progression Free Survival
22%
Exome Sequencing
21%
Genetics
19%
Cyclin B1
18%
Drive
17%
Autophagy
17%
Biogenesis
17%
Lysosome
17%
Fibroblast
17%
Mouse Model
17%
Oncogene
16%
Germline
16%
Germ Cell
16%
Tyrosine
15%
Programmed Cell Death
15%
STAT5
14%
Methylome
14%
Colony Formation
14%
Clinical Trial
14%
F-Box Protein
13%
Next Generation Sequencing
13%
Droplet Digital Polymerase Chain Reaction
12%
Skp1
12%
Circulating Tumor DNA
12%
Platelet Derived Growth Factor Receptor Alpha
12%
Murine
11%
Gene Expression Profiling
11%
Transcriptome
11%
Hematopoiesis
11%
Cell Cycle Progression
10%
Tyrosine Kinase
10%
Receptor Tyrosine Kinase
10%
Serine
9%
RNA Sequence
9%
Imatinib
9%
Epigenomics
8%
SH2 Domain
8%
Extracellular Signal-Regulated Kinases
8%
RNA Interference
8%
HAX1
8%
Observational Study
8%
Translating (Language)
8%
Mediator
8%
